DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Alsaab HO. et al.
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: Mechanism, combinations and clinical outcome.
Front Pharmacol 2017;
23: 561
We do not assume any responsibility for the contents of the web pages of other providers.